PERIMAG Trademark

Trademark Overview


On Thursday, June 2, 2016, a trademark application was filed for PERIMAG with the United States Patent and Trademark Office. The USPTO has given the PERIMAG trademark a serial number of 79192642. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Wednesday, April 17, 2024. This trademark is owned by micromod Partikeltechnologie GmbH. The PERIMAG trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

[Diagnostic preparations for medical purposes, namely, magnetizeable nano and micro particles for use in carrier-supported immunologice medical test analysis, in biochemistry or clinical chemistry, in transport- and separation-methods for medical testing for the presence of nucleic acids, tumor markers or other disease-relevant biomolecules, and in imaging tests; therapeutic pharmaceuticals, namely, magnetizeable nano and micro particles for the treatment of cancer, auto-immune diseases, or cardiovascular diseases; pharmaceutical and veterinary products, namely, magnetizeable nano and micro particles for use in targeted drug delivery and physical therapy methods, such as magnetic field-induced hyperthermia]

Chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed primarily of magnetizable material for use as contrast agents in Magnetic Resonance Imaging and Magnetic Particle Imaging for use in commercial and scientific applications; nanoparticles and microparticles composed primarily of magnetizable material for use in homing and tracking of stem cells in regenerative medicine and for hyperthermia applications for use in commercial and scientific applications; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed of both magnetizable material and organic polymers for use in biomedical research; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles that are equipped on their surface with functional properties, namely, antibody-coated, radionuclide doped, and fluorescently labeled for pharmaceutical research, cancer diagnostics and treatment r...
perimag

General Information


Serial Number79192642
Word MarkPERIMAG
Filing DateThursday, June 2, 2016
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateWednesday, April 17, 2024
Registration Number5258234
Registration DateTuesday, August 8, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2017

Trademark Statements


Goods and Services[Diagnostic preparations for medical purposes, namely, magnetizeable nano and micro particles for use in carrier-supported immunologice medical test analysis, in biochemistry or clinical chemistry, in transport- and separation-methods for medical testing for the presence of nucleic acids, tumor markers or other disease-relevant biomolecules, and in imaging tests; therapeutic pharmaceuticals, namely, magnetizeable nano and micro particles for the treatment of cancer, auto-immune diseases, or cardiovascular diseases; pharmaceutical and veterinary products, namely, magnetizeable nano and micro particles for use in targeted drug delivery and physical therapy methods, such as magnetic field-induced hyperthermia]
Goods and ServicesChemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed primarily of magnetizable material for use as contrast agents in Magnetic Resonance Imaging and Magnetic Particle Imaging for use in commercial and scientific applications; nanoparticles and microparticles composed primarily of magnetizable material for use in homing and tracking of stem cells in regenerative medicine and for hyperthermia applications for use in commercial and scientific applications; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles composed of both magnetizable material and organic polymers for use in biomedical research; chemical products for commercial and scientific purposes, namely, nanoparticles and microparticles that are equipped on their surface with functional properties, namely, antibody-coated, radionuclide doped, and fluorescently labeled for pharmaceutical research, cancer diagnostics and treatment research or stem cell treatment research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 5, 2016
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, April 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Namemicromod Partikeltechnologie GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressRostock 18119
DE

Party Namemicromod Partikeltechnologie GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party Namemicromod Partikeltechnologie GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Friday, October 7, 2016NON-FINAL ACTION WRITTEN
Saturday, October 1, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 5, 2016ASSIGNED TO EXAMINER
Saturday, October 8, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 11, 2016APPLICATION FILING RECEIPT MAILED
Saturday, October 22, 2016REFUSAL PROCESSED BY MPU
Sunday, October 23, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 11, 2016REFUSAL PROCESSED BY IB
Wednesday, April 12, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, November 8, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 27, 2017FINAL DISPOSITION PROCESSED
Monday, November 27, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 15, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 8, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, August 8, 2023TEAS SECTION 71 RECEIVED
Sunday, December 31, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, April 18, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, April 17, 2024REGISTERED - PARTIAL SEC 71 ACCEPTED
Tuesday, April 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL